Erin Godfrey
Gerontology · Riverview, FLNPI 1336640622
Payments from drug & device makers
Across 103 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$503
- AstraZeneca$275
- Mylan Specialty L.p.$126
- Takeda Pharmaceuticals U.S.A., Inc.$118
- Regeneron Healthcare Solutions, Inc.$118
- Boehringer Ingelheim$111
- plus $836 from 21 others
What the payments were for
- Food & beverage$2,086100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 28 | $503 |
| AstraZeneca | 16 | $275 |
| Mylan Specialty L.p. | 4 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $118 |
| Regeneron Healthcare Solutions, Inc. | 4 | $118 |
| Boehringer Ingelheim | 5 | $111 |
| Mallinckrodt Hospital Products Inc. | 3 | $84 |
| Paratek Pharmaceuticals, Inc. | 5 | $79 |
| Electromed, Inc. | 7 | $77 |
| Grifols USA, LLC | 3 | $70 |
| Baxter Healthcare | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 1 | $49 |
| Sanofi | 2 | $46 |
| Harmony Biosciences LLC | 2 | $41 |
| Merck | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Advanced Respiratory, Inc | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| AbbVie | 1 | $26 |
| Pharming Healthcare, Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Resmed Corp | 1 | $25 |
| United Therapeutics Corporation | 1 | $25 |
| Phadia US Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Amgen | 1 | $16 |
| Inogen, Inc. | 1 | $8 |
How this compares
$2,086 in reported general payments places this provider in the 75th percentile of 714 gerontology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 56 | $65,844 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,938 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $748 |
| Montelukast Sodium | 35 | $384 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $503 | $65,84456 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 714 gerontology providers in Florida.
Other gerontology in Riverview
- Noureen DhananiThe Villages$276K
- Flavius NascimentoCoral Springs$226K
- Michelle HartogWinter Park$90K
- Alejandra Rosales-CohenOrange City$88K
- Jennifer PacilettiAtlantis$66K
- Tatiana ClarkBradenton$34K
- Brandi LigonWinter Park$27K
- Boni MayOrlando$22K
- Dennis VerducciMiami$22K
- Christina Duffy-HenriquesMaitland$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.